Patent ID: 11859168
Assignee: CHRISTOPHER B. REID
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 13:
14. The method of claim 13, wherein the nucleated cell is transfected with a first polypeptide, or with one or more ribonucleic acids or deoxyribonucleic acids encoding a first polypeptide selected from PRR+ Numb, Oct3/4, Sox2 and Nanog; and wherein the nucleated cell is transfected with a second one or more polypeptide(s) and/or with one or more ribonucleic acids or deoxyribonucleic acids encoding the second one or more polypeptide(s) selected from PRR+ Numb, Oct4, Sox2, Nanog, Notch, LIN28, HoxB4, FGF4, LIF, LIFR, cardiotrophin, oncostatin, oncostatin receptor, IL6, hyper IL6, gp130, stat3, c-myc, CNTF, and a polypeptide with LIF activity.